1. Home
  2. RIGL
  3. RIGL News

Latest Rigel Pharmaceuticals Inc. (RIGL) News on December 22, 2024

Recent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 year
RIGL

Simply Wall St.

10 days ago

Recent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 year

RIGL

MT Newswires

13 days ago

Rigel Pharmaceuticals Reports Initial Efficacy, Safety Data from Cancer Drug Study

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition
RIGL

PR Newswire

13 days ago

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

RIGL

MT Newswires

16 days ago

B. Riley Adjusts Price Target on Rigel Pharmaceuticals to $27 From $17, Maintains Neutral Rating

RIGL

MT Newswires

20 days ago

Rigel Pharmaceuticals Says its R289 Hematology Drug Candidate Receives Fast-Track Designation From US FDA

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
RIGL

PR Newswire

20 days ago

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
RIGL

Zacks

a month ago

How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%

Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
RIGL

Zacks

a month ago

Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive

5 Relative Price Strength Options Available for Investors
RIGL

Zacks

a month ago

5 Relative Price Strength Options Available for Investors

Exploring Three High Growth Tech Stocks in the United States
RIGL

Simply Wall St.

a month ago

Exploring Three High Growth Tech Stocks in the United States

Rigel to Present at the Jefferies London Healthcare Conference
RIGL

PR Newswire

a month ago

Rigel to Present at the Jefferies London Healthcare Conference

Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
RIGL

Simply Wall St.

a month ago

Rigel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

RIGL

Thomson Reuters StreetEvents

a month ago

Q3 2024 Rigel Pharmaceuticals Inc Earnings Call

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...
RIGL

GuruFocus.com

a month ago

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...

Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates
RIGL

Zacks

a month ago

Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates

RIGL

Associated Press Finance

a month ago

Rigel: Q3 Earnings Snapshot

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
RIGL

PR Newswire

a month ago

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect
RIGL

GuruFocus.com

2 months ago

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
RIGL

PR Newswire

2 months ago

Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update
RIGL

PR Newswire

2 months ago

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)
RIGL

PR Newswire

2 months ago

Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)

RIGL

MT Newswires

2 months ago

Optime Care Expands Partnership with Rigel Pharmaceuticals

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
RIGL

GlobeNewswire

2 months ago

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

3 months ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

High Growth Tech Stocks in the United States to Watch
RIGL

Simply Wall St.

3 months ago

High Growth Tech Stocks in the United States to Watch

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?
RIGL

Zacks

3 months ago

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?

Rigel to Present at the 2024 Cantor Global Healthcare Conference
RIGL

PR Newswire

3 months ago

Rigel to Present at the 2024 Cantor Global Healthcare Conference

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
RIGL

Clinical Trials Arena

4 months ago

Rigel enrols first participant in Phase Ib/II AML treatment regimen trial

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
RIGL

PR Newswire

4 months ago

Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
RIGL

PR Newswire

4 months ago

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan

With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest
RIGL

Simply Wall St.

4 months ago

With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest

Rigel to Participate in Upcoming September Investor Conferences
RIGL

PR Newswire

4 months ago

Rigel to Participate in Upcoming September Investor Conferences

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
RIGL

Simply Wall St.

4 months ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results

RIGL

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Rigel Pharmaceuticals Inc Earnings Call

Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates
RIGL

Zacks

5 months ago

Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates

RIGL

Associated Press Finance

5 months ago

Rigel: Q2 Earnings Snapshot

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update
RIGL

PR Newswire

5 months ago

Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update

Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL

Zacks

5 months ago

Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
RIGL

Zacks

5 months ago

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?

Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL

Zacks

5 months ago

Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update
RIGL

PR Newswire

5 months ago

Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Intrinsic Value Is Potentially 87% Above Its Share Price
RIGL

Simply Wall St.

5 months ago

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Intrinsic Value Is Potentially 87% Above Its Share Price

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

5 months ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?
RIGL

Simply Wall St.

6 months ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?

RIGL

MT Newswires

6 months ago

Rigel Pharmaceuticals to Implement 1-for-10 Reverse Stock Split

RIGL

MT Newswires

6 months ago

Sector Update: Health Care Stocks Advance Pre-Bell Tuesday

Rigel Announces Reverse Stock Split
RIGL

PR Newswire

6 months ago

Rigel Announces Reverse Stock Split

RIGL

MT Newswires

6 months ago

Rigel Pharmaceuticals Completes Transfer of Gavreto New Drug Application

Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
RIGL

PR Newswire

6 months ago

Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
RIGL

PR Newswire

6 months ago

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress

Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock three years ago
RIGL

Simply Wall St.

7 months ago

Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock three years ago

Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
RIGL

PR Newswire

7 months ago

Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting

Rigel to Present at the Jefferies Global Healthcare Conference
RIGL

PR Newswire

7 months ago

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
RIGL

PR Newswire

7 months ago

Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Rigel (RIGL) Upgraded to Buy: Here's What You Should Know
RIGL

Zacks

7 months ago

Rigel (RIGL) Upgraded to Buy: Here's What You Should Know

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
RIGL

Simply Wall St.

7 months ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
RIGL

Insider Monkey

7 months ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript

RIGL

GuruFocus.com

7 months ago

Rigel Pharmaceuticals Inc (RIGL) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves ...

Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags Revenue Estimates
RIGL

Zacks

7 months ago

Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags Revenue Estimates

RIGL

Associated Press Finance

7 months ago

Rigel: Q1 Earnings Snapshot

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
RIGL

PR Newswire

7 months ago

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update

ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL

Zacks

8 months ago

ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
RIGL

Zacks

8 months ago

Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
RIGL

PR Newswire

8 months ago

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
RIGL

Zacks

8 months ago

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

8 months ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
RIGL

PR Newswire

9 months ago

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma

Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
RIGL

PR Newswire

9 months ago

Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer

Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
RIGL

GuruFocus.com

10 months ago

Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
RIGL

Insider Monkey

10 months ago

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript

RIGL

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Rigel Pharmaceuticals Inc Earnings Call

Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
RIGL

Simply Wall St.

10 months ago

Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),

Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
RIGL

Zacks

10 months ago

Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4

Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
RIGL

PR Newswire

10 months ago

Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock?
RIGL

Zacks

10 months ago

OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock?

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update
RIGL

PR Newswire

10 months ago

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update

Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
RIGL

PR Newswire

10 months ago

Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®

Can Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates?
RIGL

Zacks

10 months ago

Can Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates?

American Superconductor (AMSC) Upgraded to Buy: What Does It Mean for the Stock?
RIGL

Zacks

a year ago

American Superconductor (AMSC) Upgraded to Buy: What Does It Mean for the Stock?

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets
RIGL

Business Wire

a year ago

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets

RIGL

Associated Press Finance

a year ago

First Business Financial Services: Q4 Earnings Snapshot

First Business Financial Services Inc Reports Q4 2023 Results
RIGL

GuruFocus.com

a year ago

First Business Financial Services Inc Reports Q4 2023 Results

Carter Bankshares Inc (CARE) Faces Net Loss in Q4 2023 Amid Nonaccrual Loan Challenges
RIGL

GuruFocus.com

a year ago

Carter Bankshares Inc (CARE) Faces Net Loss in Q4 2023 Amid Nonaccrual Loan Challenges

Green Brick Partners (GRBK) Posted a 114% Gain in 2023
RIGL

Insider Monkey

a year ago

Green Brick Partners (GRBK) Posted a 114% Gain in 2023

Funko (FNKO) & Goliath Forge Exclusive Global Gaming Alliance
RIGL

Zacks

a year ago

Funko (FNKO) & Goliath Forge Exclusive Global Gaming Alliance

ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains
RIGL

Simply Wall St.

a year ago

ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains

Guaranty Bancshares, Inc. (NASDAQ:GNTY) Q4 2023 Earnings Call Transcript
RIGL

Insider Monkey

a year ago

Guaranty Bancshares, Inc. (NASDAQ:GNTY) Q4 2023 Earnings Call Transcript

NETSTREIT Corp. Announces Dates for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
RIGL

Business Wire

a year ago

NETSTREIT Corp. Announces Dates for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Natural Grocers® Provides Free Filtered Water to Communities Affected by Boil Water Advisory in Topeka, KS
RIGL

PR Newswire

a year ago

Natural Grocers® Provides Free Filtered Water to Communities Affected by Boil Water Advisory in Topeka, KS

When Will Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Become Profitable?
RIGL

Simply Wall St.

a year ago

When Will Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Become Profitable?

We Like These Underlying Return On Capital Trends At Carriage Services (NYSE:CSV)
RIGL

Simply Wall St.

a year ago

We Like These Underlying Return On Capital Trends At Carriage Services (NYSE:CSV)

The Returns On Capital At Cooper-Standard Holdings (NYSE:CPS) Don't Inspire Confidence
RIGL

Simply Wall St.

a year ago

The Returns On Capital At Cooper-Standard Holdings (NYSE:CPS) Don't Inspire Confidence

Natural Grocers® Invites Customers to Annual Resolution Reset Event, January 16-20, 2024
RIGL

PR Newswire

a year ago

Natural Grocers® Invites Customers to Annual Resolution Reset Event, January 16-20, 2024

The 7 Best REITs to Buy in January 2024
RIGL

InvestorPlace

a year ago

The 7 Best REITs to Buy in January 2024

Liberty All-Star® Growth Fund, Inc. Declares Distribution
RIGL

PR Newswire

a year ago

Liberty All-Star® Growth Fund, Inc. Declares Distribution

Raise a Toast to These 5 Consumer Discretionary Stocks in 2024
RIGL

Zacks

a year ago

Raise a Toast to These 5 Consumer Discretionary Stocks in 2024

Rigel Pharmaceuticals Provides Business Update
RIGL

PR Newswire

a year ago

Rigel Pharmaceuticals Provides Business Update

4 Top-Ranked Stocks With Solid Net Profit Margin to Buy Now
RIGL

Zacks

a year ago

4 Top-Ranked Stocks With Solid Net Profit Margin to Buy Now

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
RIGL

PR Newswire

a year ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
RIGL

PR Newswire

a year ago

Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma

Share on Social Networks: